Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

NCT03879694 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Lung Atypical Carcinoid Tumor
Lung Typical Carcinoid Tumor
Metastatic Pancreatic Neuroendocrine Tumor

Interventions

BIOLOGICAL: Incomplete Freund's Adjuvant
DRUG: Octreotide Acetate
BIOLOGICAL: Sargramostim
BIOLOGICAL: SVN53-67/M57-KLH Peptide Vaccine

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]